Key result
Leadless pacemaker and high-dose ibuprofen resolve symptoms and prevent arrhythmias in EBV-associated complete heart block.
Why the study?
EBV is a very rare cause of pericarditis, and due to a lack of literature and large-scale studies, rare life-threatening cardiac manifestations of EBV are poorly understood.
Case Report (n=1)
No
This case report describes the first known instance of subacute Epstein-Barr virus pericarditis progressing to complete heart block and cardiac arrest, successfully managed with high-dose ibuprofen and leadless permanent pacemaker implantation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for managing rare viral-induced conduction disease and should not yet change practice; leaves open the optimal long-term pacing strategy in inflammatory heart block.
Epstein-Barr virus (EBV) is a very rare cause of pericarditis, with only a handful of cases reported in the literature.1–4 Despite an overall mortality rate of only 1.1%, pericarditis can progress to life-threatening complications such as cardiac tamponade, purulent pericarditis, or pericardial effusion.5 Owing to lack of literature and large-scale studies, these rare life-threatening cardiac manifestations of EBV are poorly understood in the clinical setting. We present the case of an immunocompetent male who presented with infectious mononucleosis due to EBV.
No takes yet. Share an insight, caveat, or question.
Golzarian et al. (2023) conducted a case report in Epstein-Barr virus-associated pericarditis progressing to complete atrioventricular block and cardiac arrest (n=1). Leadless permanent pacemaker implantation and high-dose ibuprofen was evaluated on Symptom resolution and arrhythmia recurrence at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: